Search Results - Tibolla, G.

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Targeting PCSK9 for hypercholesterolemia

    Targeting PCSK9 for hypercholesterolemia by Norata, Giuseppe, Tibolla, G., Catapano, A.

    Published 2014
    Get full text
  2. 2
    Gene silencing approaches for the management of dyslipidaemia

    Gene silencing approaches for the management of dyslipidaemia by Norata, Giuseppe, Tibolla, G., Catapano, A.

    Published 2013
    Get full text
  3. 3
    Statins and skeletal muscles toxicity: From clinical trials to everyday practice

    Statins and skeletal muscles toxicity: From clinical trials to everyday practice by Norata, Giuseppe, Tibolla, G., Catapano, A.

    Published 2014
    Get full text
  4. 4
    PCSK9 inhibition for the treatment of hypercholesterolemia: Promises and emerging challenges

    PCSK9 inhibition for the treatment of hypercholesterolemia: Promises and emerging challenges by Norata, Giuseppe, Tibolla, G., Catapano, A.

    Published 2014
    Get full text
  5. 5
    HDL: To treat or not to treat?

    HDL: To treat or not to treat? by Pirillo, A., Tibolla, G., Norata, Giuseppe, Catapano, A.

    Published 2014
    Get full text
  6. 6
    Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure-function relation to therapeutic inhibition

    Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure-function relation to therapeutic inhibition by Tibolla, G., Norata, Giuseppe, Artali, R., Meneghetti, F., Catapano, A.

    Published 2011
    Get full text
  7. 7
    THE CLASS II PHOSPHOINOSITIDE 3-KINASE ISOFORM beta REGULATES PLATELET FUNCTION AND ARTERIAL THROMBOSIS IN MICE

    THE CLASS II PHOSPHOINOSITIDE 3-KINASE ISOFORM beta REGULATES PLATELET FUNCTION AND ARTERIAL THROMBOSIS IN MICE by Tibolla, G., Barbieri, S., Gianellini, S., Arnaboldi, L., Corsini, A., Tremoli, E., Falasca, Marco, Norata, G., Catapano, A.

    Published 2011
    Get full text
  8. 8
    IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the italian general population

    IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the italian general population by Dhyani, A., Tibolla, G., Baragetti, A., Garlaschelli, K., Pellegatta, F., Grigore, L., Norata, Giuseppe, Catapano, A.

    Published 2015
    Get full text
  9. 9
    Novel biotinylated bile acid amphiphiles: Micellar aggregates formation and interaction with hepatocytes

    Novel biotinylated bile acid amphiphiles: Micellar aggregates formation and interaction with hepatocytes by Rizzi, L., Braschi, M., Colombo, M., Vaiana, N., Tibolla, G., Norata, Giuseppe, Catapano, A., Romeo, S., Prosperi, D.

    Published 2011
    Get full text
  10. 10
    PI3K-C2B PLAYS A KEY ROLE IN THE ACTIVATION AND THE PROLIFERATION OF T LYMPHOCYTES: IMPACT ON VASCULAR DISEASES

    PI3K-C2B PLAYS A KEY ROLE IN THE ACTIVATION AND THE PROLIFERATION OF T LYMPHOCYTES: IMPACT ON VASCULAR DISEASES by Balzarotti, G., Tibolla, G., Bonacina, F., D'Alonzo, C., Dhyani, A., Falasca, Marco, Norata, G., Catapano, A.

    Published 2015
    Get full text
  11. 11
    Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis

    Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis by Tibolla, G., Piñeiro, R., Chiozzotto, D., Mavrommati, I., Wheeler, A., Norata, G., Catapano, A., Maffucci, T., Falasca, Marco

    Published 2013
    Get full text
  12. 12
    PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling

    PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling by Braccini, L., Ciraolo, E., Campa, C., Perino, A., Longo, D., Tibolla, G., Pregnolato, M., Cao, Y., Tassone, B., Damilano, F., Laffargue, M., Calautti, E., Falasca, Marco, Norata, G., Backer, J., Hirsch, E.

    Published 2015
    Get full text

Search Tools: